WDR72 has been recognized as a prognostic biomarker in non-small cell lung cancer, where it modulates the AKT/HIF-1α signaling pathway, contributing to enhanced lung cancer stemness (Ouyang et al., 2022; Shi et al., 2023). This evidence concerns the gene WDR72 and lung carcinoma.